NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

疫苗市場調查報告:各適應症,各流通管道-2025年為止的預測-COVID-19累積的影響

Vaccines Market Research Report by Indication, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1005052
出版日期 內容資訊 英文 186 Pages
商品交期: 最快1-2個工作天內
價格
疫苗市場調查報告:各適應症,各流通管道-2025年為止的預測-COVID-19累積的影響 Vaccines Market Research Report by Indication, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 186 Pages
簡介

全球疫苗的市場規模預計將從2020年的448億3,800萬美元,擴大到2025年末的622億249萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

本報告提供疫苗市場相關調查,提供市場概要,以及各適應症,各流通管道,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各適應症預測
  • 各流通管道預測
  • 各地區預測
  • 其他競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球疫苗市場,各適應症

  • 肛門癌
  • 子宮頸癌
  • 生殖器疣
  • 口咽癌
  • 陰莖癌
  • 陰道癌
  • 外陰癌

第7章 全球疫苗市場,各流通管道

  • 政府機關
  • 醫生的分銷商
  • 醫生
  • 公私合營
  • 批發商

第8章 南北美洲的疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲的疫苗市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Abbott Laboratories Ltd
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bavarian Nordic A/S
  • Bharat Biotech International Limited
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Merck KGaA
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Novavax, Inc.
  • Panacea Biotec Ltd
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-434CCDA05145

The Global Vaccines Market size was estimated at USD 44.83 Billion in 2020 and expected to reach USD 48.09 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 7.60% to reach USD 69.60 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Indication, the Vaccines Market was studied across Anal Cancer, Cervical Cancer, Genital Warts, Oropharyngeal Cancer, Penile Cancer, Vaginal Cancer, and Vulvar Cancer.

Based on Distribution Channel, the Vaccines Market was studied across Government Entities, Physician Distributors, Physicians, Public & Private Alliances, and Wholesalers.

Based on Geography, the Vaccines Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccines Market, including Abbott Laboratories Ltd, Astellas Pharma Inc., AstraZeneca PLC, Bavarian Nordic A/S, Bavarian Nordic A/S, Bharat Biotech International Limited, CSL Limited, Daiichi Sankyo Co., Ltd., Emergent BioSolutions, Inc., GlaxoSmithKline PLC, Inovio Pharmaceuticals, Inc., Johnson & Johnson, Merck KGaA, Mitsubishi Tanabe Pharma Corporation, Novartis AG, Novavax, Inc., Panacea Biotec Ltd, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Vaccines Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccines Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccines Market?
  • 4. What is the competitive strategic window for opportunities in the Global Vaccines Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Vaccines Market?
  • 6. What is the market share of the leading vendors in the Global Vaccines Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Indication Outlook
  • 3.4. Distribution Channel Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of infectious diseases globally
      • 5.1.1.2. Favorable government initiatives and policies for vaccine development
      • 5.1.1.3. Growing focus on immunization across the world
    • 5.1.2. Restraints
      • 5.1.2.1. High capital necessary for vaccine development
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging initiatives from companies in research and development of vaccines
      • 5.1.3.2. Integration of adjuvants in vaccines and development of therapeutic vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Issues over product recalls and inaccessibility in few regions
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Vaccines Market, by Indication

  • 6.1. Introduction
  • 6.2. Anal Cancer
  • 6.3. Cervical Cancer
  • 6.4. Genital Warts
  • 6.5. Oropharyngeal Cancer
  • 6.6. Penile Cancer
  • 6.7. Vaginal Cancer
  • 6.8. Vulvar Cancer

7. Vaccines Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Government Entities
  • 7.3. Physician Distributors
  • 7.4. Physicians
  • 7.5. Public & Private Alliances
  • 7.6. Wholesalers

8. Americas Vaccines Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Vaccines Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Vaccines Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories Ltd
  • 12.2. Astellas Pharma Inc.
  • 12.3. AstraZeneca PLC
  • 12.4. Bavarian Nordic A/S
  • 12.5. Bavarian Nordic A/S
  • 12.6. Bharat Biotech International Limited
  • 12.7. CSL Limited
  • 12.8. Daiichi Sankyo Co., Ltd.
  • 12.9. Emergent BioSolutions, Inc.
  • 12.10. GlaxoSmithKline PLC
  • 12.11. Inovio Pharmaceuticals, Inc.
  • 12.12. Johnson & Johnson
  • 12.13. Merck KGaA
  • 12.14. Mitsubishi Tanabe Pharma Corporation
  • 12.15. Novartis AG
  • 12.16. Novavax, Inc.
  • 12.17. Panacea Biotec Ltd
  • 12.18. Pfizer Inc.
  • 12.19. Sanofi SA
  • 12.20. Serum Institute of India Pvt. Ltd.
  • 12.21. Takeda Pharmaceutical Company Limited

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL VACCINES MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL VACCINES MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2026
  • FIGURE 10. GLOBAL VACCINES MARKET SIZE, BY ANAL CANCER, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL VACCINES MARKET SIZE, BY ANAL CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL VACCINES MARKET SIZE, BY CERVICAL CANCER, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL VACCINES MARKET SIZE, BY CERVICAL CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL VACCINES MARKET SIZE, BY GENITAL WARTS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL VACCINES MARKET SIZE, BY GENITAL WARTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL VACCINES MARKET SIZE, BY PENILE CANCER, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL VACCINES MARKET SIZE, BY PENILE CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL VACCINES MARKET SIZE, BY VAGINAL CANCER, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL VACCINES MARKET SIZE, BY VAGINAL CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL VACCINES MARKET SIZE, BY VULVAR CANCER, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL VACCINES MARKET SIZE, BY VULVAR CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
  • FIGURE 25. GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
  • FIGURE 27. GLOBAL VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL VACCINES MARKET SIZE, BY PHYSICIANS, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL VACCINES MARKET SIZE, BY PHYSICIANS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL VACCINES MARKET SIZE, BY WHOLESALERS, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL VACCINES MARKET SIZE, BY WHOLESALERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. AMERICAS VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 38. AMERICAS VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 40. ARGENTINA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. BRAZIL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. CANADA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. MEXICO VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. UNITED STATES VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. CALIFORNIA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. FLORIDA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. ILLINOIS VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. NEW YORK VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. OHIO VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. PENNSYLVANIA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. TEXAS VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. ASIA-PACIFIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 53. ASIA-PACIFIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 55. CHINA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. INDIA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. INDONESIA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. JAPAN VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. MALAYSIA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. PHILIPPINES VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. SOUTH KOREA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. THAILAND VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 66. FRANCE VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. GERMANY VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. ITALY VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. NETHERLANDS VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. QATAR VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. RUSSIA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. SAUDI ARABIA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. SOUTH AFRICA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. SPAIN VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. UNITED KINGDOM VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. GLOBAL VACCINES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 78. GLOBAL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 79. GLOBAL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL VACCINES MARKET SIZE, BY ANAL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL VACCINES MARKET SIZE, BY CERVICAL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL VACCINES MARKET SIZE, BY GENITAL WARTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL VACCINES MARKET SIZE, BY PENILE CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL VACCINES MARKET SIZE, BY VAGINAL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL VACCINES MARKET SIZE, BY VULVAR CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL VACCINES MARKET SIZE, BY PHYSICIANS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL VACCINES MARKET SIZE, BY WHOLESALERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. AMERICAS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. ARGENTINA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. ARGENTINA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. BRAZIL VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. BRAZIL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. CANADA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. CANADA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. MEXICO VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. MEXICO VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. UNITED STATES VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. UNITED STATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. CALIFORNIA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. CALIFORNIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. FLORIDA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. FLORIDA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. ILLINOIS VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. ILLINOIS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. NEW YORK VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. NEW YORK VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. OHIO VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. OHIO VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. PENNSYLVANIA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. PENNSYLVANIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. TEXAS VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. TEXAS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. ASIA-PACIFIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. ASIA-PACIFIC VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. ASIA-PACIFIC VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. CHINA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. CHINA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. INDIA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. INDIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. INDONESIA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. INDONESIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. JAPAN VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. JAPAN VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. MALAYSIA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. MALAYSIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. PHILIPPINES VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. PHILIPPINES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. SOUTH KOREA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. SOUTH KOREA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. THAILAND VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. THAILAND VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. FRANCE VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. FRANCE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. GERMANY VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. GERMANY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. ITALY VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. ITALY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. NETHERLANDS VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. NETHERLANDS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. QATAR VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. QATAR VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. RUSSIA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. RUSSIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SAUDI ARABIA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SAUDI ARABIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. SOUTH AFRICA VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. SOUTH AFRICA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SPAIN VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. SPAIN VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. UNITED KINGDOM VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. UNITED KINGDOM VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. GLOBAL VACCINES MARKET: SCORES
  • TABLE 90. GLOBAL VACCINES MARKET: BUSINESS STRATEGY
  • TABLE 91. GLOBAL VACCINES MARKET: PRODUCT SATISFACTION
  • TABLE 92. GLOBAL VACCINES MARKET: RANKING
  • TABLE 93. GLOBAL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 94. GLOBAL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • TABLE 95. GLOBAL VACCINES MARKET: MERGER & ACQUISITION
  • TABLE 96. GLOBAL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 97. GLOBAL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 98. GLOBAL VACCINES MARKET: INVESTMENT & FUNDING
  • TABLE 99. GLOBAL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 100. GLOBAL VACCINES MARKET: LICENSE & PRICING
  • TABLE 101. GLOBAL VACCINES MARKET: CONTACT DETAILS